Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018



Summary



GlobalData’s new report, “Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global immunochemistry market. The report provides market landscape, competitive landscape and market trends information on the immunochemistry market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Anemia/ Vitamin Tests, Disease Specific Immunochemistry, Drugs of Abuse/Toxicology, Therapeutic Drug Monitoring, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests, Organ Function Assays and Specific Proteins.
- Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018, and company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints within clinical chemistry market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare and Abbott Laboratories.



Reasons to buy


- Develop business strategies by understanding the trends and developments that are driving the immunochemistry globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify the key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the immunochemistry market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global immunochemistry market and the factors shaping it.

Table Of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 GlobalData Report Guidance 9
3 Immunochemistry Overview 10
3.1 Immunochemistry, Market Segmentation 10
3.1.1 Anemia/Vitamin Tests 11
3.1.2 Disease Specific Immunochemistry 11
3.1.3 Drugs of Abuse/Toxicology 13
3.1.4 Therapeutic Drug Monitoring (TDM) 14
3.1.5 Endocrinology Tests 15
3.1.6 Immunochemistry Analyzers 16
3.1.7 Immunochemistry Rapid Tests 16
3.1.8 Organ Function Assays 16
3.1.9 Specific Proteins 16
4 Immunochemistry - Global Market Characterization 17
4.1 Immunochemistry Market, Global, Revenue ($m), Historic, 2004 - 2011 17
4.2 Immunochemistry Market, Global, Revenue ($m), Forecast, 2011 - 2018 18
4.3 Immunochemistry Market, Key Trends 19
4.3.1 Improvement in Software, Hardware Technology and User Interface to Improve Immunochemistry Analyzers Adoption Rate 19
4.3.2 Advent of Home Based Testing Methods to Lead to Increase in Demand for Diagnostic Testing 20
4.3.3 Point of Care Testing (POCT) to be in High Demand but Adoption will Depend on Technological Developments in this Field 21
4.4 Immunochemistry, Market Dynamics 22
4.4.1 Market Drivers 22
4.4.2 Market Restraints 31
5 Global Immunochemistry Market - Analysis by Segment 35
5.1 Anemia/ Vitamin Test Market, Global, Revenue ($m), Historic, 2004 - 2011 35
5.2 Anemia/ Vitamin Test Market, Global, Revenue ($m), Forecast, 2011 - 2018 36
5.3 Anemia/ Vitamin Test Market, Market Dynamics 37
5.3.1 Market Drivers 37
5.3.2 Market Restraint 40
5.4 Disease Specific Immunochemistry Market, Global, Revenue ($m), Historic, 2004 - 2011 41
5.5 Disease Specific Immunochemistry Market, Global, Revenue ($m), Forecast, 2011 - 2018 42
5.6 Disease Specific Immunochemistry, Market Dynamics 43
5.6.1 Market Drivers 43
5.6.2 Market Restraints 49
5.7 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Historic, 2004 - 2011 51
5.8 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Forecast, 2011 - 2018 52
5.9 Drugs of Abuse/Toxicology, Market Dynamics 53
5.9.1 Market Drivers 53
5.9.2 Market Restraints 57
5.10 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Historic, 2004 - 2011 58
5.11 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Forecast, 2011 - 2018 59
5.12 Therapeutic Drug Monitoring, Market Dynamics 60
5.12.1 Market Driver 60
5.12.2 Market Restraint 60
5.13 Endocrinology Tests Market, Global, Revenue ($m), Historic, 2004 - 2011 62
5.14 Endocrinology Tests Market, Global, Revenue ($m), Forecast, 2011 - 2018 63
5.15 Endocrinology Tests, Market Dynamics 64
5.15.1 Market Driver 64
5.15.2 Market Restraint 65
5.16 Immunochemistry Analyzers Market, Global, Revenue ($m), Historic, 2004 - 2011 66
5.17 Immunochemistry Analyzers Market, Global, Revenue ($m), Forecast, 2011 - 2018 67
5.18 Immunochemistry Analyzers, Market Dynamics 68
5.18.1 Market Driver 68
5.18.2 Market Restraint 68
5.19 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Historic, 2004-2011 69
5.20 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Forecast, 2011-2018 70
5.21 Immunochemistry Rapid Tests, Market Dynamics 71
5.21.1 Market Driver 71
5.21.2 Market Restraint 71
5.22 Organ Function Assays Market, Global, Revenue ($m), Historic, 2004-2011 72
5.23 Organ Function Assays Market, Global, Revenue ($m), Forecast, 2011-2018 73
5.24 Organ Function Assays, Market Dynamics 74
5.24.1 Market Driver 74
5.24.2 Market Restraint 74
5.25 Specific Proteins Market, Global, Revenue ($m), Historic, 2004-2011 75
5.26 Specific Proteins Market, Global, Revenue ($m), Forecast, 2011-2018 76
5.27 Specific Proteins, Market Dynamics 77
5.27.1 Market Driver 77
5.27.2 Market Restraint 77
6 Immunochemistry Market, Analysis by Country, Revenue ($m), 2004 - 2018 78
6.1 Immunochemistry Market, the US, Revenue ($m), Historic, 2004-2011 78
6.2 Immunochemistry Market, the US, Revenue ($m), Forecast, 2011-2018 79
6.3 Immunochemistry Market, Canada, Revenue ($m), Historic, 2004-2011 80
6.4 Immunochemistry Market, Canada, Revenue ($m), Forecast, 2011-2018 81
6.5 Immunochemistry Market, the UK, Revenue ($m), Historic, 2004-2011 82
6.6 Immunochemistry Market, the UK, Revenue ($m), Forecast, 2011-2018 83
6.7 Immunochemistry Market, Germany, Revenue ($m), Historic, 2004-2011 84
6.8 Immunochemistry Market, Germany, Revenue ($m), Forecast, 2011-2018 85
6.9 Immunochemistry Market, France, Revenue ($m), Historic, 2004-2011 86
6.10 Immunochemistry Market, France, Revenue ($m), Forecast, 2011-2018 87
6.11 Immunochemistry Market, Italy, Revenue ($m), Historic, 2004-2011 88
6.12 Immunochemistry Market, Italy, Revenue ($m), Forecast, 2011-2018 89
6.13 Immunochemistry Market, Spain, Revenue ($m), Historic, 2004-2011 90
6.14 Immunochemistry Market, Spain, Revenue ($m), Forecast, 2011-2018 91
6.15 Immunochemistry Market, Japan, Revenue ($m), Historic, 2004-2011 92
6.16 Immunochemistry Market, Japan, Revenue ($m), Forecast, 2011-2018 93
6.17 Immunochemistry Market, China, Revenue ($m), Historic, 2004-2011 94
6.18 Immunochemistry Market, China, Revenue ($m), Forecast, 2011-2018 95
6.19 Immunochemistry Market, India, Revenue ($m), Historic, 2004-2011 96
6.20 Immunochemistry Market, India, Revenue ($m), Forecast, 2011-2018 97
6.21 Immunochemistry Market, Australia, Revenue ($m), Historic, 2004-2011 98
6.22 Immunochemistry Market, Australia, Revenue ($m), Forecast, 2011-2018 99
6.23 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2004-2011 100
6.24 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018 101
7 Immunochemistry Market - Strategic Competitive Assessment 102
7.1 Immunochemistry, Key Market Participants 103
7.1.1 Siemens Healthcare Inc. 103
7.1.2 F. Hoffmann-La Roche Ltd. 109
7.1.3 Abbott Laboratories 114
8 Immunochemistry - Strategic Pipeline Assessment 119
9 Immunochemistry Market - Strategic Deals Analysis 121
9.1 High Number of Partnerships Characterizing the Deal Landscape 122
9.2 Investments by PE/VC Firms to Spur Innovation in Immunochemistry Market 122
9.3 Key Deals 122
9.3.1 Ventana Medical Enters into a Number of Companion Diagnostics Partnerships with Multiple Partners 122
9.3.2 Dako Enters into Co-development Agreement with Amgen 123
9.3.3 Sigma-Aldrich Completes Acquisition of BioReliance for $350m 123
9.3.4 Pronota Raises $4.8m in Series C Financing 124
9.3.5 Roche Enters into Joint Venture Agreement with Swiss Federal Institute of Technology, University of Zurich and University Hospital Zurich 124
9.3.6 Affymetrix to acquire eBioscience for $330m 124
10 Appendix 126
10.1 Market Definitions 126
10.1.1 Immunochemistry 126
10.2 Acronyms 129
10.3 Research Methodology 132
10.3.1 Secondary Research 132
10.3.2 Primary Research 132
10.3.3 Models 133
10.3.4 Forecasts 133
10.3.5 Expert Panels 133
10.3.6 GlobalData Consulting 133
10.3.7 Contact Us 134
10.3.8 Disclaimer 134
10.4 Sources 134
10.4.1 Corporate, Industry and Government Sources 134
10.4.2 Journals 136
10.4.3 Online Publications 136
10.4.4 Press Releases 137

List of Tables

Table 1: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 17
Table 2: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 18
Table 3: Companion Diagnostics in Immunochemistry 22
Table 4: Roche, Number of Companion Diagnostic Projects, 2006-2010 23
Table 5: Companion Diagnostics, Value Proposition Analysis 25
Table 6: Companion Diagnostics, Number of Partnerships, 2004-2010 26
Table 7: Number of Corporate Diagnostic Laboratory Chains, India, 2010 29
Table 8: Comparison of Various Finance Options 30
Table 9: Laboratory Acquisitions, the US, 2002-2008 33
Table 10: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011 35
Table 11: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018 36
Table 12: Percentage of Factors Contributing to Anemia Prevalence 37
Table 13: Correlation of Anemia and Economic Conditions 38
Table 14: Vitamin D Diagnosis, Product Approvals, 1999-2011 39
Table 15: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 41
Table 16: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 42
Table 17: Newly Discovered Tumor Markers, 2008-2011 43
Table 18: Principle of Action, Tumor Markers 44
Table 19: Prevalence Rate of Various Allergies, the US, 2001-2010 45
Table 20: Prevalence of Respiratory Symptoms and Risk Factors Among Children Aged between 6-11 Years, the UK, 2007-2008 46
Table 21: Prevalence of Autoimmune Diseases, Global, 2010 47
Table 22: Autoimmune Disease Research Funding, the US, 2005-2011 48
Table 23: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011 51
Table 24: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018 52
Table 25: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010 53
Table 26: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010 54
Table 27: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010 55
Table 28: Drug Tests, Olympics (Summer and Winter), 2000-2010 57
Table 29: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011 58
Table 30: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018 59
Table 31: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010 61
Table 32: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011 62
Table 33: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018 63
Table 34: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011 66
Table 35: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018 67
Table 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 69
Table 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 70
Table 38: Use of Immunoassay Detection Test, by Diagnosed Disease 71
Table 39: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 72
Table 40: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 73
Table 41: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 75
Table 42: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 76
Table 43: Immunochemistry Market, the US, Revenue ($m), 2004-2011 78
Table 44: Immunochemistry Market, the US, Revenue ($m), 2011-2018 79
Table 45: Immunochemistry Market, Canada, Revenue($m), 2004-2011 80
Table 46: Immunochemistry Market, Canada, Revenue ($m), 2011-2018 81
Table 47: Immunochemistry Market, the UK, Revenue ($m), 2004-2011 82
Table 48: Immunochemistry Market, the UK, Revenue ($’000), 2011-2018 83
Table 49: Immunochemistry Market, Germany, Revenue ($m), 2004-2011 84
Table 50: Immunochemistry Market, Germany, Revenue ($m), 2011-2018 85
Table 51: Immunochemistry Market, France, Revenue ($m), 2004-2011 86
Table 52: Immunochemistry Market, France, Revenue ($m), 2011-2018 87
Table 53: Immunochemistry Market, Italy, Revenue ($m), 2004-2011 88
Table 54: Immunochemistry Market, Italy, Revenue ($m), 2011-2018 89
Table 55: Immunochemistry Market, Spain, Revenue ($), 2004-2011 90
Table 56: Immunochemistry Market, Spain, Revenue ($m), 2011-2018 91
Table 57: Immunochemistry Market, Japan, Revenue ($m), 2004-2011 92
Table 58: Immunochemistry Market, Japan, Revenue ($’000), 2011-2018 93
Table 59: Immunochemistry Market, China, Revenue ($m), 2004-2011 94
Table 60: Immunochemistry Market, China, Revenue ($m), 2011-2018 95
Table 61: Immunochemistry Market, India, Revenue ($m), 2004-2011 96
Table 62: Immunochemistry Market, India, Revenue ($m), 2011-2018 97
Table 63: Immunochemistry Market, Australia, Revenue ($m), 2004-2011 98
Table 64: Immunochemistry Market, Australia, Revenue ($m), 2011-2018 99
Table 65: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011 100
Table 66: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018 101
Table 67: Immunochemistry Market, Global, Company Share (%), 2011 102
Table 68: Siemens Healthcare, Immunochemistry Portfolio*, 2011 103
Table 69: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment 104
Table 70: Siemens Healthcare, Emerging Markets Growth, 2008-2010 107
Table 71: F. Hoffmann-La Roche Ltd., Immunochemistry Portfolio*, 2011 109
Table 72: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment 110
Table 73: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010 113
Table 74: Abbott Laboratories, Immunochemistry Portfolio*, 2011 114
Table 75: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment 115
Table 76: Immunochemistry, Global Pipeline Products, 2011 119
Table 77: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011 120
Table 78: Immunochemistry Market, Deals, 2009-2011 121

List of Figures

Figure 1: Immunochemistry, Market Segmentation 10
Figure 2: Disease Specific Immunochemistry, Market Segmentation 11
Figure 3: Drugs of Abuse/Toxicology, Market Segmentation 13
Figure 4: Therapeutic Drug Monitoring, Market Segmentation 14
Figure 5: Endocrinology Tests, Market Segmentation 15
Figure 6: Immunochemistry Analyzers, Market Segmentation 16
Figure 7: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 17
Figure 8: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 18
Figure 9: Immunochemistry, Market Dynamics 22
Figure 10: Roche, Number of Companion Diagnostic Projects, 2006-2010 23
Figure 11: Companion Diagnostics, Value Proposition Analysis 24
Figure 12: Companion Diagnostics, Number of Partnerships, 2004-2010 26
Figure 13: Hub and Spoke Model used by Diagnostic Laboratories 29
Figure 14: Laboratory Acquisitions, the US, 2002-2008 32
Figure 15: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011 35
Figure 16: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018 36
Figure 17: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 41
Figure 18: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 42
Figure 19: Autoimmune Disease Research Funding, the US, 2005-2011 48
Figure 20: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011 51
Figure 21: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018 52
Figure 22: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010 53
Figure 23: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010 54
Figure 24: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010 55
Figure 25: Drug Tests, Olympics (Summer and Winter), 2000-2010 56
Figure 26: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011 58
Figure 27: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018 59
Figure 28: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010 61
Figure 29: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011 62
Figure 30: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018 63
Figure 31: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011 66
Figure 32: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018 67
Figure 33: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 69
Figure 34: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 70
Figure 35: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 72
Figure 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 73
Figure 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 75
Figure 38: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 76
Figure 39: Immunochemistry Market, the US, Revenue ($m), 2004-2011 78
Figure 40: Immunochemistry Market, the US, Revenue ($m), 2011-2018 79
Figure 41: Immunochemistry Market, Canada, Revenue($m), 2004-2011 80
Figure 42: Immunochemistry Market, Canada, Revenue ($m), 2011-2018 81
Figure 43: Immunochemistry Market, the UK, Revenue ($m), 2004-2011 82
Figure 44: Immunochemistry Market, the UK, Revenue ($m), 2011-2018 83
Figure 45: Immunochemistry Market, Germany, Revenue ($m), 2004-2011 84
Figure 46: Immunochemistry Market, Germany, Revenue ($m), 2011-2018 85
Figure 47: Immunochemistry Market, France, Revenue ($m), 2004-2011 86
Figure 48: Immunochemistry Market, France, Revenue ($m), 2011-2018 87
Figure 49: Immunochemistry Market, Italy, Revenue ($m), 2004-2011 88
Figure 50: Immunochemistry Market, Italy, Revenue ($m), 2011-2018 89
Figure 51: Immunochemistry Market, Spain, Revenue ($m), 2004-2011 90
Figure 52: Immunochemistry Market, Spain, Revenue ($m), 2011-2018 91
Figure 53: Immunochemistry Market, Japan, Revenue ($m), 2004-2011 92
Figure 54: Immunochemistry Market, Japan, Revenue ($m), 2011-2018 93
Figure 55: Immunochemistry Market, China, Revenue ($m), 2004-2011 94
Figure 56: Immunochemistry Market, China, Revenue ($m), 2011-2018 95
Figure 57: Immunochemistry Market, India, Revenue ($m), 2004-2011 96
Figure 58: Immunochemistry Market, India, Revenue ($m), 2011-2018 97
Figure 59: Immunochemistry Market, Australia, Revenue ($m), 2004-2011 98
Figure 60: Immunochemistry Market, Australia, Revenue ($m), 2011-2018 99
Figure 61: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011 100
Figure 62: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018 101
Figure 63: Immunochemistry Market, Global, Company Share (%), 2011 102
Figure 64: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment 104
Figure 65: Siemens Healthcare, SWOT Analysis, 2011 105
Figure 66: Siemens Healthcare, Revenue Share, by Region, 2010 106
Figure 67: Siemens Healthcare, Emerging Markets Growth, 2008-2010 106
Figure 68: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment 110
Figure 69: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2011 111
Figure 70: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010 113
Figure 71: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment 115
Figure 72: Abbott Laboratories, SWOT Analysis, 2011 116
Figure 73: Immunochemistry, Global Pipeline Products, 2011 119
Figure 74: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011 120
Figure 75: Immunochemistry Market, Deals, 2009-2011 121

Companies mentioned
Siemens Healthcare Inc.
F. Hoffmann-La Roche Ltd.
Abbott Laboratories

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.